2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.
The challenges faced by globalisation are evolving in real time. For those concentrating on Asia-Pacific, here are the top three worth-noting development.
China’s political landscape is complex. In this article, we take a close look at its intricate political environment, the importance of strategic insight, and what businesses can do to engage in the policy-shaping process.
AI is transforming healthcare. We delve into the variety of ongoing and anticipated applications for AI in healthcare and the approaches that key markets are taking for regulation, also highlighting AI’s application towards challenging therapeutic areas.
COP28 has arrived at the significant midpoint between the 2015 Paris Agreement (COP21) and 2030. Will the conclusions of the Global Stocktake accelerate climate action?
As society becomes more aware of issues related to gender, diversity, equity and inclusion (DEI), there is a growing need to use more inclusive language.
A brief introduction to China’s leadership structure for those who are interested in tracking China's policy development and its economic implications.
What are the implications of a new Labour government for the Australian healthcare industry? How brands can adjust their government relations efforts to make connections with the new administration?
Despite domestic and external uncertainties, during the "Two Sessions", China announced a series of policy backstops to stabilise growth, generate confidence...